Phase 2 Estimation Study of Fixed Dose Drugs Combination Type of Polypill

Clinical trial NCT06597058 · COMPLETED

Trial details

NCT number: NCT06597058
Sponsor: Noah Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2024-10-16
Primary completion: 2025-11-05
Enrollment: 121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.